https://www.europesays.com/ch/126761/ Yuhan to Distribute Novartis Hives Drug Rhapsido in Korea #BTKInhibitor #ChronicSpontaneousUrticaria #lesigercept #Novartis #NovartisKorea #remibrutinib #Rhapsido® #Yuhan
#btkinhibitor — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #btkinhibitor, aggregated by home.social.
-
https://www.europesays.com/at/240046/ Nach Studienerfolg: Lilly vor entscheidendem Europa-Coup: Kommt jetzt der nächste Wachstumstreiber? | wallstreetONLINE #BTKInhibitor #ChronischeLymphatischeLeukämie #EU #EUZulassung #Europa #Europe #Jaypirca #Lilly
-
https://www.europesays.com/ch/58992/ Genentech fenebrutinib cuts relapsing MS relapses 51%-59% #BrainLesions #BTKInhibitor #fenebrutinib #Genentech #PhaseIIITrial #RelapseReduction #RelapsingMultipleSclerosis #RHHBY #Roche
-
https://www.europesays.com/ch/53240/ Roche fenebrutinib cuts RMS relapses 51%-59% #AnnualisedRelapseRate #BrainLesions #BTKInhibitor #fenebrutinib #PhaseIII #RelapsingMultipleSclerosis #RHHBY #Roche
-
https://www.europesays.com/ch/31459/ Genentech fenebrutinib slashes MS relapses 51% #BTKInhibitor #fenebrutinib #Genentech #MultipleSclerosis #PhaseIII #PrimaryProgressiveMS #RelapseRate #RelapsingMS #RHHBY #Roche #teriflunomide
-
https://www.europesays.com/uk/753430/ Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News #BTKInhibitor #Fenebrutinib #FENtrepid #Health #Medication #MultipleSclerosis #Ocrevus #pharma #PPMS #R&D #Roche #Sanofi #Tolebrutinib #UK #UnitedKingdom
-
"In a multinational, phase 3, head-to-head trial, ibrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor, was compared with zanubrutinib, a BTK inhibitor with greater specificity, as treatment for relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)"
#Leukemia #TyrosineKinase #BTKInhibitor
https://www.nejm.org/doi/full/10.1056/NEJMoa2211582?query=featured_home